Equivalent cross-relaxation rate imaging of axillary lymph nodes in breast cancer

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 6, 2008, Pages 1278-1283

  Mastsushima, Shigeru ^a   Nishiofuku, Hideyuki ^b   Iwata, Hiroji ^c   Era, Seiichi ^a   Inaba, Yoshitaka ^c   Kinosada, Yasutomi ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast cancer; Cellular imaging; Equivalent cross relaxation rate; Magnetization transfer; Molecular imaging; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; METASTASIS; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 44449137004     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21355     Document Type: Article

References (19)

1. Sakorafas GH, Peros G, Cataliotti L, Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006;15:153-165.
2. Keshtgar MR, Ell PJ. Clinical role of sentinel-lymph-node biopsy in breast cancer. Lancet Oncol 2002;3:105-110.
3. Schuster DM, Halkar RK. Molecular imaging in breast cancer. Radiol Clin North Am 2004;42:885-908.
4. Moran PR, Hamilton CA. Near-resonance spin-lock contrast. Magn Reson Imaging 1995;13:837-846.
5. Era S, Sogami M, Kinosada Y, Matsushima S, Kato K, Nagai N. Magnetization transfer in protein solution gel, and polymer gel. In: Proceedings of the International Workshop on Magnetic Resonance and other Spectroscopic Techniques to Food Science, Harima, Japan, 1997. p 107-110.
6. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006;111):343-351.
7. Unno N, Inuzuka K, Suzuki M, et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg 2007;45:1016-1021.
8. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J Control Release 2006;111:343-351.
9. Torchia MG, Nason R, Danzinger R, Lewis JM, Thliveris JA. Interstitial MR lymphangiography for the detection of sentinel lymph nodes. Surg Oncol 2001;78:151-156.
10. Torchia MG, Misselwitz B. Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17. AJR Am J Roentgenol 2002;179:1561-1565.
11. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N. Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent. Preliminary observations in dogs and humans. Acta Radiol 2003;44:35-42.
12. Staatz G, Spuntrup E, Buecker A, Misselwitz B, Gunther RW. T1-weighted MR-lymphography after intramammary administration of Gadomer-17 in pigs. Rofo 2002;174:29-32.
13. Kobayashi H, Kawamoto S, Choyke PL, Sato N, Brechbiel MW. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 2003;50:758-766.
14. Sogami M, Era S, Kinosada Y, et al. Basic studies on the equivalent cross-relaxation rate imaging (equivalent CRI) phantom studies. NMR Biomed 2001;367-375.
15. Matsushima S, Takasu A, Inai Y, et al. Equivalent cross-relaxation rate imaging in the synthetic copolymer gels and invasive ductal carcinoma of the breast. Magn Reson Imaging 2002;20:285-293.
16. Yuen S, Yamada K, Kinosada Y, et al. Equivalent cross-relaxation rate imaging of breast cancer. J Magn Reson Imaging 2004;20:56-65.
17. Matsushima S, Sasaki F, Sarumaru S, et al. Equivalent cross-relaxation rate image for decreasing a false negative case of sentinel node biopsy. Magn Reson Imaging 2003;21:1045-1047.
18. Matsushima S, Sasaki F, Yamaura H, et al. Equivalent cross-relaxation rate imaging for sentinel lymph node biopsy in breast carcinoma. Magn Reson Med 2005;54:1300-1304.
19. Zaremba L. FDA guidance for MR system safety and patient exposures: current status and future considerations. In: Magnetic resonance procedures: health effects and safety. Boca Ration, FL: CRC Press; 2001. p 183-196.